In development: Guidance, quality standards and advice
Showing 1 to 1 of 1
| Title | Type | Expected publication date |
|---|---|---|
| Decitabine–cedazuridine with venetoclax for treating acute myeloid leukaemia when intensive induction chemotherapy is unsuitable [ID6601] | Technology appraisal guidance | TBC |